• Terms and Conditions
  • Privacy Policy
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Contact Us
Sixsense News
Advertisement
  • Home
  • Business
  • Economy
  • Fintech
  • Finance
  • Insurance
  • Market
  • Startups
No Result
View All Result
  • Home
  • Business
  • Economy
  • Fintech
  • Finance
  • Insurance
  • Market
  • Startups
No Result
View All Result
Sixsense News
No Result
View All Result
Home Business

Microsoft offers EU remedies seeking OK on Activision deal By Reuters

Reuters by Reuters
March 17, 2023
in Business
0

Related articles

Rockwell Medical, Inc. (RMTI) Q4 2022 Earnings Call Transcript

March 30, 2023

Analysts say next week’s BoI rate hike won’t be the last

March 30, 2023


© Reuters. FILE PHOTO: Microsoft logo is seen on a smartphone placed on displayed Activision Blizzard’s games characters in this illustration taken January 18, 2022. REUTERS/Dado Ruvic/Illustration

By Foo Yun Chee

BRUSSELS (Reuters) – Microsoft Corp (NASDAQ:) has offered remedies in an attempt to gain EU antitrust approval for its $69 billion acquisition of Activision, a European Commission filing showed on Friday.

The EU competition enforcer, which did not provide details in line with its policy, will now seek feedback from rivals and customers before making its decision by May 22.

Microsoft President Brad Smith has said the U.S. software company was prepared to offer rivals licensing deals to ease competition concerns but not to selling Activision’s lucrative “Call of Duty” franchise.

The company has in recent weeks signed agreements with three companies to bring “Call of Duty” to their platforms.

“We have stood behind our promise to bring Call of Duty to more gamers on more devices by entering into agreements to bring the game to the Nintendo console and cloud game streaming services offered by Nvidia (NASDAQ:), Boosteroid, and Ubitus,” a spokesperson said.

“We are now backing up that promise with binding commitments to the European Commission, which will ensure that this deal benefits gamers into the future.”

The company is likely to win EU clearance for the deal with such licensing deals and other behavioural remedies, sources have told Reuters while the jury is still out on whether the UK competition enforcer will do the same.

Tags: ActivisiondealMicrosoftoffersremediesReutersSeeking

Related Posts

Rockwell Medical, Inc. (RMTI) Q4 2022 Earnings Call Transcript

by Freddie Green
March 30, 2023
0

Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2022 Earnings Conference Call March 30, 2023 8:00 AM ET Company Participants Heather Hunter -...

Analysts say next week’s BoI rate hike won’t be the last

by Aharon Katz
March 30, 2023
0

The analysts' consensus sees the Bank of Israel raising the interest rate on Monday by 0.25% to 4.5% - a...

Nifty sheds 431 pts in March F&O series, Nifty Bank slips 91 pts — here’s what to expect in April | Nifty 50, Nifty Bank in March FO series

by zee business
March 30, 2023
0

Indian equity benchmark Nifty 50 finished the March derivatives (futures and options) series with a loss of 430.6 points — which is...

Zeon charts its 1st fund raise and pan-India EV charging network expansion

by Freddie Green
March 30, 2023
0

Zeon Electric Pvt Ltd, which runs the electric passenger vehicle charging network across south India, is preparing to raise Series...

Layoffs In March 2023: Microsoft, Disney, And Others

by Sakshat Kolhatkar
March 30, 2023
0

Layoffs In March 2023: Microsoft, Disney, And Others Business NewsLayoffs In March 2023: Microsoft, Disney, And Others30 Mar 2023, 6:31...

Load More

Rockwell Medical, Inc. (RMTI) Q4 2022 Earnings Call Transcript

March 30, 2023

Exclusive-Germans shun foreign deposits on fear of new crisis By Reuters

March 30, 2023

Analysts say next week’s BoI rate hike won’t be the last

March 30, 2023

Nifty sheds 431 pts in March F&O series, Nifty Bank slips 91 pts — here’s what to expect in April | Nifty 50, Nifty Bank in March FO series

March 30, 2023

PicsArt Photo & Video Editing App Latest Version

March 30, 2023

Diffusion to merge with EIP Pharma in all-stock deal

March 30, 2023
Sixsense News

© 2022 Sixsense News All Rights Reserved.

Navigate Site

  • Terms and Conditions
  • Privacy Policy
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Contact Us

Follow Us

No Result
View All Result
  • #3158 (no title)
  • Business
  • Economy
  • Finance
  • Fintech
  • Insurance
  • Market
  • Startups

© 2022 Sixsense News All Rights Reserved.